Find policies, billing codes, payers, states, and providers
CPT 87480: Direct Nucleic Acid Probe Test for Candida Species
CPT code 87480 denotes a direct nucleic acid probe test for Candida species performed by a laboratory analyst. This molecular diagnostic code covers targeted testing that identifies Candida organisms from clinical specimens and is a key tool in diagnosing fungal infections. Nationally, such tests influence infection management, antimicrobial stewardship, and laboratory service utilization.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the clinical context for 87480, typical sites of service, and the service type. The publication also summarizes benchmark information where available, common billing considerations, and recent policy updates that affect coverage and coding practice.
The content clarifies how 87480 fits within laboratory and infectious disease workflows, highlights payer coverage trends and policy implications for reimbursement and utilization, and outlines areas where organizations should verify local payer rules. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 87480 policy alerts
Get alerted when payer policies referencing 87480 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 87480 describes a laboratory test in which a lab analyst performs direct nucleic acid probe testing for Candida species. The procedure uses molecular probe techniques applied directly to a clinical specimen to detect and identify Candida organisms.
-
Service type: Diagnostic molecular microbiology test
-
Typical site of service: Clinical laboratory or hospital laboratory setting